Found: 24
Select item for more details and to access through your institution.
Extracellular fluid concentrations of cisplatin, carboplatin, and oxaliplatin in brain, muscle, and blood measured using microdialysis in nonhuman primates.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 817, doi. 10.1007/s00280-009-1085-7
- By:
- Publication type:
- Article
Epidermal growth factor receptor (EGFR) mRNA levels and protein expression levels in primary colorectal cancer and corresponding liver metastases.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 825, doi. 10.1007/s00280-009-1087-5
- By:
- Publication type:
- Article
A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 833, doi. 10.1007/s00280-009-1088-4
- By:
- Publication type:
- Article
Limited inter-occasion variability in relation to inter-individual variability in chemotherapy-induced myelosuppression.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 839, doi. 10.1007/s00280-009-1089-3
- By:
- Publication type:
- Article
Cetuximab-based therapy versus non-cetuximab therapy for advanced cancer: a meta-analysis of 17 randomized controlled trials.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 849, doi. 10.1007/s00280-009-1090-x
- By:
- Publication type:
- Article
A phase I dose escalation study of a pharmacobiologically based scheduling of capecitabine and mitomycin C in patients with gastrointestinal malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 863, doi. 10.1007/s00280-009-1091-9
- By:
- Publication type:
- Article
A phase IB dose-finding trial of liposomal doxorubicin in combination with capecitabine in patients with pretreated metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 871, doi. 10.1007/s00280-009-1092-8
- By:
- Publication type:
- Article
Induction of necrosis and cell cycle arrest in murine cancer cell lines by Melaleuca alternifolia (tea tree) oil and terpinen-4-ol.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 877, doi. 10.1007/s00280-009-1093-7
- By:
- Publication type:
- Article
Expression of an activated mammalian target of rapamycin (mTOR) in gastroenteropancreatic neuroendocrine tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 889, doi. 10.1007/s00280-009-1094-6
- By:
- Publication type:
- Article
Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 895, doi. 10.1007/s00280-009-1095-5
- By:
- Publication type:
- Article
Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 903, doi. 10.1007/s00280-009-1097-3
- By:
- Publication type:
- Article
Optimization of the non-invasive (13)C-sucrose breath test in a rat model of methotrexate-induced mucositis.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Optimization of the non-invasive <sup>13</sup>C-sucrose breath test in a rat model of methotrexate-induced mucositis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 913, doi. 10.1007/s00280-009-1098-2
- By:
- Publication type:
- Article
Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 923, doi. 10.1007/s00280-009-1099-1
- By:
- Publication type:
- Article
Antimetastatic, antineoplastic, and toxic effects of 4-hydroxycoumarin in a preclinical mouse melanoma model.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 931, doi. 10.1007/s00280-009-1100-z
- By:
- Publication type:
- Article
Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of gamma-glutamyl transpeptidase.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 941, doi. 10.1007/s00280-009-1101-y
- By:
- Publication type:
- Article
Co-administration of irinotecan decreases the plasma concentration of an active metabolite of amrubicin, amrubicinol in rats.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 953, doi. 10.1007/s00280-009-1102-x
- By:
- Publication type:
- Article
Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 961, doi. 10.1007/s00280-009-1103-9
- By:
- Publication type:
- Article
Increased anti-tumour effects of doxorubicin and zoledronic acid in prostate cancer cells in vitro: supporting the benefits of combination therapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 969, doi. 10.1007/s00280-009-1106-6
- By:
- Publication type:
- Article
A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapy.
- Published in:
- 2010
- By:
- Publication type:
- Report
DNA damage induced by the anthracycline cosmomycin D in DNA repair-deficient cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 989, doi. 10.1007/s00280-010-1244-x
- By:
- Publication type:
- Article
In vitro assessment of cytochrome P450 inhibition and induction potential of azacitidine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 995, doi. 10.1007/s00280-010-1245-9
- By:
- Publication type:
- Article
Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 1001, doi. 10.1007/s00280-010-1258-4
- By:
- Publication type:
- Article